Coverage and Cost Impacts of the President’s Health Insurance Tax Credit and Tax Deduction Proposals February 29, 2004 Issue Brief This issue brief looks at the coverage impacts and costs of two components of the administration’s FY 2005 budget proposals to increase the affordability of health insurance: a new tax credit for people purchasing non-group health insurance and a new tax deduction for premiums for high-deductible, non-group health insurance policies.…
Retiree Health Benefits Now and In the Future – Chartpack December 31, 2003 Report This chartpack (charts used at the briefing releasing this survey), from the survey conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003, provides detailed information on retiree health programs offered by large private-sector employers. The data in this survey reflect the responses of 408 large…
Retiree Health Benefits in 2003: Employer Survey December 31, 2003 Report This survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers. The data in this survey reflect the responses of 408 large firms (private-sector employers with 1,000 or more workers) and provides information…
Retiree Health Benefits Now and in the Future, Report December 31, 2003 Report Retiree Health Benefits Now and In the Future – ReportThis survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers. The data in this survey reflect the responses of 408 large firms (private-sector…
Prescription Drug Coverage for Medicare Beneficiaries: A Side-by-Side Comparison of S. 1 and H.R. 1 and the Conference Agreement H.R. 1 November 1, 2003 Report This document, prepared by Health Policy Alternatives, Inc., provides a detailed side-by-side comparison of the prescription drug provisions of the Conference Agreement (H.R. 1) passed by the House and Senate in November 2003 and the House (H.R. 1) and Senate (S. 1) Medicare proposals passed in June 2003.Report (.pdf)
Designing a Medicare Drug Discount Card: Implications of Policy Choices for Medicare Beneficiaries and Plan Sponsors October 30, 2003 Report This report analyzes key issues surrounding the implementation of a Medicare-endorsed prescription drug discount card program. Medicare prescription drug discount cards have been proposed as a short-term strategy for lowering prescription drug costs for Medicare beneficiaries. The report considers the implications for both discount card sponsors and beneficiaries of alternative…
Cost of Health Insurance: Section 1 – Page 3 October 20, 2003 Report Employer Health Benefits 2003 Annual SurveyView All Charts for This Section Monthly Premium Costs of Single and Family CoverageIn 2003, average monthly premiums for single and family coverage (including worker and employer share of premium) are $282 and $756 respectively (Exhibit 1.12). The cost of family coverage is now nearly…
California Health Insurance Act (SB2) Data Update September 29, 2003 Report On October 5, 2003, Governor Gray Davis signed into law the California Health Insurance Act of 2003 (also referred to as SB2). This law would require employers with 200 or more workers to either pay into a fund that will provide coverage to their workers or to pay for 80%…
Kaiser/HRET Survey: 2002 State Employee Health Plans July 1, 2003 Report Kaiser/HRET Survey: 2002 State Employee Health PlansState employee health plans provided coverage for 3.4 million state government employees in 2002. The Kaiser/HRET Survey: 2002 State Employee Health Plans finds that premiums for state employee health plans increased 12.8% in 2002, similar to national averages. It also finds that state employee…
Impact of Direct-to-Consumer Advertising on Prescription Drug Spending June 10, 2003 Report A new study by researchers at Harvard University and the Massachusetts Institute of Technology looks at the effect of direct-to-consumer (DTC) advertising on spending for prescription drugs. The study found that, on average, a 10% increase in DTC advertising of drugs within a therapeutic drug class resulted in a 1% increase in sales of the drugs in that class.